These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 105327)

  • 1. [Antibacterial activity of fosfomycin in chronic kidney infections].
    Schena FP; Selvaggi FP; Montagna MT; Salvatore C
    Minerva Med; 1978 Dec; 69(59):4097-104. PubMed ID: 105327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of nevigramon in acute and chronic pyelonephritis before and after kidney transplantation].
    Iarmolinskiĭ IS; Vasina TA; Ploshkina NS; Goriaĭnov VA
    Antibiotiki; 1971 Feb; 16(2):177-9. PubMed ID: 4997523
    [No Abstract]   [Full Text] [Related]  

  • 3. [Our experience in the use of fosfomycin in human therapy].
    De Rosa F; Pauselli A; Matocci G; Petrucci G
    Minerva Med; 1978 Dec; 69(59):4115-8. PubMed ID: 105328
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical chemotherapeutic evaluation of fosfomycin plus amoxicillin (co-fosfolactamine): a prospective double-blind clinical trial.
    Novelli A; Rizzo M; Buzzoni P; Coronnello M; Alunno Pergentini S; Giganti E; Periti P
    Chemioterapia; 1984 Oct; 3(5):281-5. PubMed ID: 6398125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fosfomycin therapy for multiresistant Pseudomonas aeruginosa in cystic fibrosis.
    Mirakhur A; Gallagher MJ; Ledson MJ; Hart CA; Walshaw MJ
    J Cyst Fibros; 2003 Mar; 2(1):19-24. PubMed ID: 15463841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinico-therapeutic and microbiologic studies of the Bulgarian antibiotic cephalothin in patients with active pyelonephritis].
    Astrug A; Gavrilov G; Todorova L; Lobutova M; Tsenova Z
    Vutr Boles; 1983; 22(6):62-9. PubMed ID: 6369792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic guidelines in the management of urinary tract infections and pyelonephritis.
    Turck M
    Urol Clin North Am; 1975 Oct; 2(3):443-50. PubMed ID: 1103409
    [No Abstract]   [Full Text] [Related]  

  • 8. [Nephrological experiences in the treatment of urinary infections by fosfomycin].
    Mioli V; Figus S
    Minerva Med; 1978 Dec; 69(59):4093-6. PubMed ID: 740305
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fosfomycin--a new antibiotic in rhinootolaryngology].
    Stammberger H
    HNO; 1983 Dec; 31(12):436-9. PubMed ID: 6662741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe renal failure in acute bacterial pyelonephritis: do not forget corticosteroids.
    Sqalli TH; Hamzaoui H; Guiard E; Noel LH; Fakhouri F
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):118-22. PubMed ID: 20061705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiological basis for the use of fosfomycin trometamol as single-dose therapy for simple cystitis.
    Gismondo MR; Romeo MA; Lo Bue AM; Chisari G; Nicoletti G
    Chemioterapia; 1986 Aug; 5(4):278-82. PubMed ID: 3094965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unexpected Activity of Oral Fosfomycin against Resistant Strains of Escherichia coli in Murine Pyelonephritis.
    Pourbaix A; Guérin F; Burdet C; Massias L; Chau F; Cattoir V; Fantin B
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31160291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical response of chemotherapeutic agents with different activities on chronic complicated pyelonephritis with renal stone. A proposed index of local antimicrobial activity].
    Suzuki K; Horiba M; Nagata Y; Naide Y
    Hinyokika Kiyo; 1991 Sep; 37(9):963-8. PubMed ID: 1785421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
    Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Rodríguez-Baño J; Alcalá JC; Cisneros JM; Grill F; Oliver A; Horcajada JP; Tórtola T; Mirelis B; Navarro G; Cuenca M; Esteve M; Peña C; Llanos AC; Cantón R; Pascual A
    Arch Intern Med; 2008 Sep; 168(17):1897-902. PubMed ID: 18809817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug sensitivity of urinary microflora and the effect of treatment in exacerbated chronic pyelonephritis].
    Robeva R; Gruev I; Vasilev T; Neshev Kh
    Vutr Boles; 1986; 25(3):68-74. PubMed ID: 3765581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of ceftriaxone treatment in acute pyelonephritis caused by extended-spectrum beta-lactamase-producing bacteria.
    Suankratay C; Jutivorakool K; Jirajariyavej S
    J Med Assoc Thai; 2008 Aug; 91(8):1172-81. PubMed ID: 18788687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of antibacterial therapy in chronic obstructive urinary tract infections].
    Hofmann W; Rumohr T; Patsch R
    Z Urol Nephrol; 1987 Oct; 80(10):595-600. PubMed ID: 3324549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections.
    Pullukcu H; Tasbakan M; Sipahi OR; Yamazhan T; Aydemir S; Ulusoy S
    Int J Antimicrob Agents; 2007 Jan; 29(1):62-5. PubMed ID: 17189097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands?
    Knottnerus BJ; Nys S; Ter Riet G; Donker G; Geerlings SE; Stobberingh E
    J Antimicrob Chemother; 2008 Aug; 62(2):356-9. PubMed ID: 18424789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.